PML is a key component for the differentiation of myeloid progenitor cells to macrophages

International Immunology

Volumn 23, Issue 4, 2011, Pages 287-296

  Khalfin Rabinovich, Yana ^a   Weinstein, Adaya ^a   Levi, Ben Zion ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

IFN regulatory factor 8 (IRF 8); Monopoiesis; Myeloid cell differentiation; Transcriptional regulation

Indexed keywords

INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; BONE MARROW CELL; CELL DIFFERENTIATION; COLONY FORMING CELL; GENE; GENE CONTROL; GENE EXPRESSION PROFILING; GENE SILENCING; GENE TARGETING; GRANULOCYTE; GRANULOPOIESIS; MACROPHAGE; MONOCYTE; MOUSE; MYELOID PROGENITOR CELL; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA GENE;

EID: 79953325701     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxr004     Document Type: Article

References (55)

1. Rosenbauer, F. and Tenen, D. G. 2007. Transcription factors in myeloid development: balancing differentiation with transformation. Nat. Rev. Immunol. 7:105.
2. Rosmarin, A. G., Yang, Z. and Resendes, K. K. 2005. Transcriptional regulation in myelopoiesis: hematopoietic fate choice, myeloid differentiation, and leukemogenesis. Exp. Hematol. 33:131.
3. Orkin, S. H. 2000. Diversification of haematopoietic stem cells to specific lineages. Nat. Rev. Genet. 1:57.
4. Tamura, T., Nagamura-Inoue, T., Shmeltzer, Z., Kuwata, T. and Ozato, K. 2000. ICSBP directs bipotential myeloid progenitor cells to differentiate into mature macrophages. Immunity 13:155.
5. Holtschke, T., Lohler, J., Kanno, Y. et al. 1996. Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87:307.
6. Schmidt, M., Nagel, S., Proba, J. et al. 1998. Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood 91:22.
7. Levi, B. Z., Hashmueli, S., Gleit-Kielmanowicz, M., Azriel, A. and Meraro, D. 2002. ICSBP/IRF-8 transactivation: a tale of proteinprotein interaction. J. Interferon. Cytokine. Res. 22:153.
8. Eklund, E. A. and Kakar, R. 1999. Recruitment of CREB-binding protein by PU.1, IFN-regulatory factor-1, and the IFN consensus sequence-binding protein is necessary for IFN-gamma-induced p67phox and gp91phox expression. J. Immunol. 163:6095.
9. Marecki, S. and Fenton, M. J. 2000. PU.1/interferon regulatory factor interactions: mechanisms of transcriptional regulation. Cell. Biochem. Biophys. 33:127.
10. Alter-Koltunoff, M., Ehrlich, S., Dror, N. et al. 2003. Nramp1 mediated innate resistance to intraphagosomal pathogens is regulated by IRF-8, PU.1 and Miz-1. J. Biol. Chem. 278:44025.
11. Dror, N., Alter-Koltunoff, M., Azriel, A. et al. 2007. Identification of IRF-8 and IRF-1 target genes in activated macrophages. Mol. Immnol. 44:338.
12. Dror, N., Rave-Harel, N., Burchert, A. et al. 2007. IRF-8 is indispensable for the expression of PML and the formation of nuclear bodies in myeloid cells. J. Biol. Chem. 282:5633.
13. de The, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L. and Dejean, A. 1991. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 66:675.
14. Jensen, K., Shiels, C. and Freemont, P. S. 2001. PML protein isoforms and the RBCC/TRIM motif. Oncogene 20:7223.
15. Salomoni, P. and Pandolfi, P. P. 2002. The role of PML in tumor suppression. Cell 108:165.
16. Bernardi, R. and Pandolfi, P. P. 2007. Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies. Nat. Rev. Mol. Cell Biol. 8:1006.
17. Dellaire, G. and Bazett-Jones, D. P. 2004. PML nuclear bodies: dynamic sensors of DNA damage and cellular stress. Bioessays 26:963.
18. Ching, R. W., Dellaire, G., Eskiw, C. H. and Bazett-Jones, D. P. 2005. PML bodies: a meeting place for genomic loci? J. Cell. Sci. 118:847.
19. Pandolfi, P. P., Roth, M. E., Karis, A. et al. 1995. Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat. Genet. 11:40.
20. Wang, Z. G., Delva, L., Gaboli, M. et al. 1998. Role of PML in cell growth and the retinoic acid pathway. Science 279:1547.
21. Tsai, S. and Collins, S. J. 1993. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc. Natl Acad. Sci. U. S. A 90:7153.
22. Lin, R. J., Sternsdorf, T., Tini, M. and Evans, R. M. 2001. Transcriptional regulation in acute promyelocytic leukemia. Oncogene 20:7204.
23. Zimonjic, D. B., Pollock, J. L., Westervelt, P., Popescu, N. C. and Ley, T. J. 2000. Acquired, nonrandom chromosomal abnormalities associated with the development of acute promyelocytic leukemia in transgenic mice. Proc. Natl Acad. Sci. U. S. A. 97:13306.
24. Alter-Koltunoff, M., Goren, S., Nousbeck, J. et al. 2008. Innate immunity to intraphagosomal pathogens is mediated by interferon regulatory factor 8 (IRF-8) that stimulates the expression of macrophage-specific Nramp1 through antagonizing repression by c-Myc. J. Biol. Chem. 283:2724.
25. Xiong, H., Li, H., Kong, H. J. et al. 2005. Ubiquitin-dependent degradation of interferon regulatory factor-8 mediated by Cbl downregulates interleukin-12 expression. J. Biol. Chem. 280:23531.
26. Tenen, D. G., Hromas, R., Licht, J. D. and Zhang, D. E. 1997. Transcription factors, normal myeloid development, and leukemia. Blood 90:489.
27. Radomska, H. S., Huettner, C. S., Zhang, P., Cheng, T., Scadden, D. T. and Tenen, D. G. 1998. CCAAT/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors. Mol. Cell. Biol. 18:4301.
28. Krieger, M. and Herz, J. 1994. Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein (LRP). Annu. Rev. Biochem. 63:601.
29. Guertin, F., Brunet, S., Gavino, V., Tuchweber, B. and Levy, E. 1995. Malondialdehyde-modified HDL leads to accumulation of cholesterol in rat liver endothelial cells. Biochem. Biophys. Res. Commun. 212:1.
30. Roth, P. and Stanley, E. R. 1992. The biology of CSF-1 and its receptor. Curr. Top. Microbiol. Immunol. 181:141.
31. Byrne, P. V., Guilbert, L. J. and Stanley, E. R. 1981. Distribution of cells bearing receptors for a colony-stimulating factor (CSF-1) in murine tissues. J. Cell Biol. 91:848.
32. Nauseef, W. M., Metcalf, J. A. and Root, R. K. 1983. Role of myeloperoxidase in the respiratory burst of human neutrophils. Blood 61:483.
33. Koeffler, H. P., Ranyard, J. and Pertcheck, M. 1985. Myeloperoxidase: its structure and expression during myeloid differentiation. Blood 65:484.
34. Dahl, R. and Simon, M. C. 2003. The importance of PU.1 concentration in hematopoietic lineage commitment and maturation. Blood Cells. Mol. Dis 31:229.
35. Rosenbauer, F., Wagner, K., Kutok, J. L. et al. 2004. Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. Nat. Genet. 36:624.
36. Okuda, T., van Deursen, J., Hiebert, S. W., Grosveld, G. and Downing, J. R. 1996. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 84:321.
37. Testa, U., Stellacci, E., Pelosi, E. et al. 2004. Impaired myelopoiesis in mice devoid of interferon regulatory factor 1. Leukemia 18:1864.
38. Akashi, K., Traver, D., Miyamoto, T. and Weissman, I. L. 2000. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 404:193.
39. Valledor, A. F., Borras, F. E., Cullell-Young, M. and Celada, A. 1998. Transcription factors that regulate monocyte/macrophage differentiation. J. Leukoc. Biol. 63:405.
40. Krishnaraju, K., Hoffman, B. and Liebermann, D. A. 1998. The zinc finger transcription factor Egr-1 activates macrophage differentiation in M1 myeloblastic leukemia cells. Blood 92: 1957.
41. Krishnaraju, K., Hoffman, B. and Liebermann, D. A. 2001. Early growth response gene 1 stimulates development of hematopoietic progenitor cells along the macrophage lineage at the expense of the granulocyte and erythroid lineages. Blood 97:1298.
42. Krishnaraju, K., Nguyen, H. Q., Liebermann, D. A. and Hoffman, B. 1995. The zinc finger transcription factor Egr-1 potentiates macrophage differentiation of hematopoietic cells. Mol. Cell Biol. 15:5499.
43. Lee, S. L., Wang, Y. and Milbrandt, J. 1996. Unimpaired macrophage differentiation and activation in mice lacking the zinc finger transplantation factor NGFI-A (EGR1). Mol. Cell Biol. 16:4566.
44. Laslo, P., Spooner, C. J., Warmflash, A. et al. 2006. Multilineage transcriptional priming and determination of alternate hematopoietic cell fates. Cell 126:755.
45. Xiong, H., Zhu, C., Li, H. et al. 2003. Complex formation of the interferon (IFN) consensus sequence-binding protein with IRF-1 is essential for murine macrophage IFN-gamma-induced iNOS gene expression. J. Biol. Chem. 278:2271.
46. Kim, Y. M., Kang, H. S., Paik, S. G. et al. 1999. Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression. J. Immunol. 163:2000.
47. Marecki, S., Riendeau, C. J., Liang, M. D. and Fenton, M. J. 2001. PU.1 and multiple IFN regulatory factor proteins synergize to mediate transcriptional activation of the human IL-1 beta gene. J. Immunol. 166:6829.
48. Tsujimura, H., Tamura, T., Kong, H. J. et al. 2004. Toll-like receptor signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J. Immunol. 172:6820.
49. Reuss, E., Fimmers, R., Kruger, A., Becker, C., Rittner, C. and Hohler, T. 2002. Differential regulation of interleukin-10 production by genetic and environmental factors-a twin study. Genes. Immun. 3:407.
50. Ford, A. M., Bennett, C. A., Healy, L. E., Towatari, M., Greaves, M. F. and Enver, T. 1996. Regulation of the myeloperoxidase enhancer binding proteins Pu1, C-EBP alpha, -beta, and -delta during granulocyte-lineage specification. Proc. Natl Acad. Sci. U. S. A. 93:10838.
51. Eklund, E. A., Jalava, A. and Kakar, R. 1998. PU.1, interferon regulatory factor 1, and interferon consensus sequence-binding protein cooperate to increase gp91(phox) expression. J. Biol. Chem. 273:13957.
52. Tsujimura, H., Nagamura-Inoue, T., Tamura, T. and Ozato, K. 2002. IFN consensus sequence binding protein/IFN regulatory factor-8 guides bone marrow progenitor cells toward the macrophage lineage. J. Immunol. 169:1261.
53. Coulombel, L. 2004. Identification of hematopoietic stem/progenitor cells: strength and drawbacks of functional assays. Oncogene 23:7210.
54. Scheller, M., Foerster, J., Heyworth, C. M. et al. 1999. Altered development and cytokine responses of myeloid progenitors in the absence of transcription factor, interferon consensus sequence binding protein. Blood 94:3764.
55. Ito, K., Bernardi, R., Morotti, A. et al. 2008. PML targeting eradicates quiescent leukaemia-initiating cells. Nature 19:1072.